Company Profile

USBiomaterials Corporation
Profile last edited on: 8/14/07      CAGE:       UEI:

Business Identifier: Technologies to restore tissue structure and function
Year Founded
----
First Award
2002
Latest Award
2002
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3740 Beach Boulevard Suite 304
Jacksonville Beach, FL 32207
   (386) 418-1551
   Admin@usbiomat.com
   www.usbiomat.com
Location: Single
Congr. District: 05
County: Duval

Public Profile

USBiomaterials ("USB") develops products that restore tissue structure and function, leveraging a single proprietary science platform into three different product development categories. This science platform is a series of inorganic, bioactive material formulations - composed entirely of elements naturally occurring in body chemistry -- that release ions into local body environments in concentrations needed to facilitate key biological processes at that site. The Company has already commercialized products in one of the three platforms, thereby demonstrating FDA approvability, safety and efficacy, and the Company's ability to execute its plans. This first platform is bone graft substitutes (NovaBone® and PerioGlas®) that offer a more natural regeneration response than "growth factors", but with similar stimulatory effects. USB is developing products for its second platform (NovaMin (tm)) - a tooth remineralizer that is safer and works faster and in a broader range of situations than the current standard of fluoride. Significant commercial alliances for this are already in place, with more in late-stage negotiation. The Company is also confirming proof-of-concept for its third platform ("CSM Technology"), which offers localized anti-inflammatory (anti-TNF) effects, with target applications for inflammatory skin conditions (i.e. psoriasis) and post-surgical inflammatory complications. Beyond a versatile, well-documented core technology, USB has extensive corporate capabilities and resources as well: USB's headquarters and research labs in Gainesville, Florida house a technical staff with extensive experience combining the materials sciences and life sciences. The company maintains research relationships with several universities including the University of Florida, University of Maryland and Imperial College (U.K.). The company has a well-developed regulatory affairs capability and has received clearances for products in over 25 nations, including the U.S., Canada, the European Community countries, and China. This combination of a dynamic, well documented core technology with multiple opportunities for commercial success and solid corporate capabilities for additional research and commercialization offers USBiomaterials Corporation an exciting future

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
20-24
Revenue Range
2M-2.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
20-24

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2002 1 NIH $98,527
Project Title: Novel Bioactive Glass Dentifrice Formulations

Key People / Management

  Randolph Scott -- President

  David C Greenspan -- Vice President

Company News

There are no news available.